Evidence map›Paper›PMID 40234446›Full record

ArticleSchizophrenia (Heidelberg, Germany)2025

Pathways to prevention: the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) Program.

Barnaby Nelson, Martha E Shenton, Scott W Woods, Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ)

Abstract readEditorial
In one paragraph

Article in Schizophrenia (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Barnaby NelsonCentre for Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia. barnaby.nelson@orygen.org.au.
Martha E ShentonHarvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-4235-7879
Scott W WoodsYale University, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-3103-5228
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ)

Funding

ProNET: Psychosis-Risk Outcomes NetworkU01MH124639 · NIMH · YALE UNIVERSITY · PI CARRIE E BEARDEN, JOHN M KANE · 2020 to 2026
$81.2M
Psychosis Risk Evaluation, Data Integration and Computational Technologies (PREDICT): Data Processing, Analysis, and Coordination CenterU24MH124629 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI Rene S. Kahn, Martha E. Shenton · 2020 to 2026
$32.6M
Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT)U01MH124631 · NIMH · UNIVERSITY OF MELBOURNE · PI Christopher Barnaby Nelson · 2020 to 2026
$30.4M
NIMH NIH HHS U01 MH124631NIMH NIH HHS U01 MH124639NIMH NIH HHS U24 MH124629U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) U24MH124629, U01MH124631, and U01MH124639Wellcome TrustWellcome Trust (Wellcome) 220664/Z/20/Z and 220664/A/20/Z
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40234446
PMCPMC12000314

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.